Ellen Kurek

News
Utilization of Genetic Testing Among Commercially Insured Patients With Ovarian Cancer
05/13/2022
Study findings reveal only 33.9% of commercially insured patients with ovarian cancer received germline BRCA testing, despite guideline recommendations.
Study findings reveal only 33.9% of commercially insured patients with ovarian cancer received germline BRCA testing, despite guideline recommendations.
Study findings reveal only 33.9%...
05/13/2022
Journal of Clinical Pathways
Conference Coverage
Use of Homologous Recombination Thresholds for Forecasting Response to Platinum-Based Treatment in Triple-Negative Breast Cancer
06/14/2022
Researchers at ASCO conducted an exploratory analysis evaluating the ability of GIS thresholds of 33 or greater, and 42 or greater to predict response to platinum-based treatment in patients with triple-negative breast cancer.
Researchers at ASCO conducted an exploratory analysis evaluating the ability of GIS thresholds of 33 or greater, and 42 or greater to predict response to platinum-based treatment in patients with triple-negative breast cancer.
Researchers at ASCO conducted an...
06/14/2022
Journal of Clinical Pathways
News
Preoperative Short-Term Radiotherapy Followed by Chemotherapy vs Standard Schedule of Long-Term Chemoradiotherapy for the Treatment of Locally Advanced Rectal Cancer
05/31/2022
Short-term radiotherapy with preoperative chemotherapy followed by surgery may be efficacious with acceptable toxicity and could be used as an alternative to chemoradiotherapy among patients with locally advanced rectal cancer.
Short-term radiotherapy with preoperative chemotherapy followed by surgery may be efficacious with acceptable toxicity and could be used as an alternative to chemoradiotherapy among patients with locally advanced rectal cancer.
Short-term radiotherapy with...
05/31/2022
Journal of Clinical Pathways
News
Artificial Intelligence-Powered Spatial Analysis of TILs Predicts Treatment Outcomes With ICIs in NSCLC
05/16/2022
Researchers developed a whole-slide image analyzer powered by artificial intelligence that could detect three immune phenotypes that correlated with treatment outcomes to immune checkpoint inhibitors among patients with NSCLC.
Researchers developed a whole-slide image analyzer powered by artificial intelligence that could detect three immune phenotypes that correlated with treatment outcomes to immune checkpoint inhibitors among patients with NSCLC.
Researchers developed a...
05/16/2022
Journal of Clinical Pathways
News
Study Estimates Treatment-Related Prior Authorization Costs for Radiation Oncology Practices Nationwide
04/20/2022
An analysis of internal processes by physicians in a radiation oncology practice at Vanderbilt University Medical Center determined that the time and cost burdens of treatment-related prior authorizations for such practices are substantial...
An analysis of internal processes by physicians in a radiation oncology practice at Vanderbilt University Medical Center determined that the time and cost burdens of treatment-related prior authorizations for such practices are substantial...
An analysis of internal...
04/20/2022
Journal of Clinical Pathways
News
Barriers to Financial Assistance Among Patients With Cancer Experiencing Financial Distress
06/24/2022
Findings from a recent study identified a need for systematic implementation of oncology financial navigation to address patient and caregiver financial hardship.
Findings from a recent study identified a need for systematic implementation of oncology financial navigation to address patient and caregiver financial hardship.
Findings from a recent study...
06/24/2022
Journal of Clinical Pathways
News
Breast Conservation Yields Equal QOL Outcomes to Mastectomy and Reconstruction Among Patients With Breast Cancer
05/17/2022
A comparative effectiveness study showed that patients with early–stage breast cancer had similar quality of life outcomes after breast-conserving surgery with RT and after mastectomy and reconstruction without RT.
A comparative effectiveness study showed that patients with early–stage breast cancer had similar quality of life outcomes after breast-conserving surgery with RT and after mastectomy and reconstruction without RT.
A comparative effectiveness...
05/17/2022
Journal of Clinical Pathways
News
Evaluating Attrition Rates and Treatment Outcomes Among Patients With MCL
07/14/2022
Findings from a recent real-world analysis on patients with mantle cell lymphoma revealed high attrition rates, as well as a need for more effective treatment options for those in earlier lines of therapy.
Findings from a recent real-world analysis on patients with mantle cell lymphoma revealed high attrition rates, as well as a need for more effective treatment options for those in earlier lines of therapy.
Findings from a recent...
07/14/2022
Journal of Clinical Pathways
News
Systematic Review Determines the Incidence of Tumor Lysis Syndrome With Tyrosine Kinase Inhibitors in Hematologic Malignancies
06/01/2022
A recent systematic review found that the overall number of articles commenting on TLS as an adverse event is sparse and there needs to be more transparency regarding the incidence of TLS when employing newer targeted therapies.
A recent systematic review found that the overall number of articles commenting on TLS as an adverse event is sparse and there needs to be more transparency regarding the incidence of TLS when employing newer targeted therapies.
A recent systematic review found...
06/01/2022
Journal of Clinical Pathways
News
Systematic Review Protocol Explores Impact of Bortezomib in Multiple Myeloma Treatment
07/27/2022
Researchers detailed their systematic review protocol which will aim to evaluate the effects of bortezomib on the overall survival, progression-free survival, overall response rate, time to next treatment, health-related quality of life,...
Researchers detailed their systematic review protocol which will aim to evaluate the effects of bortezomib on the overall survival, progression-free survival, overall response rate, time to next treatment, health-related quality of life,...
Researchers detailed their...
07/27/2022
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use